Mason Street Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
GCM
CCM
RIM
SCA
KCM
Mason Street Advisors's LMAT Position: Q1 2021 in Review
Mason Street Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2021, closing a stake of 6,296 shares — an estimated $255K sold.
Mason Street Advisors first reported a position in LMAT in Q2 2017 and held it in 15 quarters. The position peaked at $255K in Q4 2020. 179 funds tracked by Wall St. Rank hold LMAT as of Q1 2021.
- Mason Street Advisors reported no remaining LeMaitre Vascular position as of Q1 2021 after selling out during the quarter.
- Mason Street Advisors sold 6,296 LeMaitre Vascular shares in Q1 2021, an estimated $255K.
- Mason Street Advisors first reported a position in LeMaitre Vascular in Q2 2017 and held it in 15 quarters.
- Mason Street Advisors's LeMaitre Vascular position peaked at $255K in Q4 2020.
- 179 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2021.
Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.